IRIS
PELAIA, GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.881
AS - Asia 3.210
EU - Europa 1.462
SA - Sud America 1.040
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 9.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.715
SG - Singapore 1.481
BR - Brasile 822
CN - Cina 705
IT - Italia 704
VN - Vietnam 423
IN - India 336
DE - Germania 186
GB - Regno Unito 155
SE - Svezia 143
CA - Canada 117
AR - Argentina 98
HK - Hong Kong 71
FI - Finlandia 70
EC - Ecuador 43
ID - Indonesia 41
BD - Bangladesh 34
MX - Messico 30
NL - Olanda 28
RU - Federazione Russa 24
ES - Italia 23
PY - Paraguay 21
UA - Ucraina 20
FR - Francia 19
PL - Polonia 19
TR - Turchia 18
ZA - Sudafrica 18
CL - Cile 16
IQ - Iraq 16
JP - Giappone 16
CZ - Repubblica Ceca 13
PE - Perù 13
CO - Colombia 11
PK - Pakistan 11
EG - Egitto 10
MA - Marocco 10
VE - Venezuela 10
DO - Repubblica Dominicana 9
IE - Irlanda 9
UZ - Uzbekistan 8
LT - Lituania 7
RO - Romania 7
AT - Austria 6
AU - Australia 6
IL - Israele 6
KE - Kenya 6
EU - Europa 5
SA - Arabia Saudita 5
TW - Taiwan 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DZ - Algeria 4
IR - Iran 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
MY - Malesia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
HR - Croazia 3
PT - Portogallo 3
TN - Tunisia 3
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KR - Corea 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GY - Guiana 1
KG - Kirghizistan 1
LV - Lettonia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
NE - Niger 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
Totale 9.665
Salva come PNG Salva come JPEG
Città #
Chandler 574
Singapore 481
Dallas 366
Santa Clara 304
Bengaluru 289
Hefei 288
Milan 245
Lawrence 227
Princeton 227
Ho Chi Minh City 168
Ashburn 161
Wilmington 144
Munich 120
Chicago 114
London 114
Ottawa 91
Beijing 86
Hanoi 85
São Paulo 76
Des Moines 71
Hong Kong 69
Catanzaro 67
Turku 52
Boardman 47
Los Angeles 30
Shanghai 30
Naples 29
New York 25
Rio de Janeiro 25
Rome 24
Da Nang 22
San Francisco 22
Quito 20
Atlanta 19
Brooklyn 19
Guangzhou 19
Redwood City 19
Warsaw 19
Norwalk 18
The Dalles 18
Palermo 17
Seattle 17
Biên Hòa 16
Buenos Aires 16
Hanover 16
San Nicola Manfredi 16
Boston 15
Haiphong 15
Helsinki 15
Redmond 15
Troina 15
Belo Horizonte 14
Olomouc 13
Thái Bình 13
Columbus 12
Curitiba 12
Florence 12
Guayaquil 12
Mexico City 12
Phoenix 12
Tokyo 12
Ankara 11
Lima 11
Salvador 11
Hải Dương 10
Campinas 9
Council Bluffs 9
Pune 9
Shenzhen 9
Asunción 8
Brasília 8
Dhaka 8
Dublin 8
Johannesburg 8
Ninh Bình 8
Osasco 8
Tashkent 8
Toronto 8
Amsterdam 7
Augusta 7
Bauru 7
Cape Town 7
Falls Church 7
Goiânia 7
Guarulhos 7
Mendoza 7
Porto Alegre 7
Rogliano 7
Stockholm 7
Wuhan 7
Assago 6
Baghdad 6
Bologna 6
Bắc Giang 6
Ferrara 6
Florianópolis 6
Londrina 6
Mountain View 6
Nairobi 6
Padova 6
Totale 5.416
Salva come PNG Salva come JPEG
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 101
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 86
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 82
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 80
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 75
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 73
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 70
Application of proteomics and peptidomics to COPD 69
High-flow nasal oxygen therapy in intensive care and anaesthesia 67
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 63
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 62
Asthma and COPD proteomics: Current approaches and future directions 61
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 61
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 59
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 59
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 59
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 58
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 57
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 57
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 56
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 56
Type 2 severe asthma: pathophysiology and treatment with biologics 55
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 55
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 55
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 54
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 54
A case of alveolar proteinosis associated with pulmonary nocardiosis 54
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 54
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 53
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 53
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 53
Alpha-interferon and its effects on signal transduction pathways 52
Airways smooth muscle response to biological stimuli 51
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 51
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 50
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases 50
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 50
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 50
Anticolinergici 49
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 49
Adverse drug reactions in hospitalized patients following antibiotics administration 48
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 48
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 48
Valutazione in doppio cieco dell’effetto broncodilatante del procaterolo somministrato per aerosol dosato 48
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 47
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 47
Adverse drug reactions in hospitalized patients following NSAIDs administration 47
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 47
Early management of COPD: where are we now and where do we go from here? 47
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 47
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma 47
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 46
Agonisti beta2-adrenergici 46
Emerging biological treatments for asthma 45
Adverse drug reaction in two pneumology units of Catanzaro 45
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 45
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 44
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 44
Adverse drug reactions in hospitalized patients following bronchodilators administration 44
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 44
The severe asthma network in Italy: findings and perspectives 43
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 43
Effects of MAPK inhibitors on H2O2-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells 43
Basi fisiopatologiche della terapia del broncospasmo 43
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 43
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 43
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 43
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 43
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 43
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 42
Oxygenation strategies during flexible bronchoscopy: a review of the literature 42
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 42
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 42
Role of biologics in severe eosinophilic asthma - focus on reslizumab 41
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 41
T CELL ACTIVATION STATE IN THE INDUCED SPUTUM OF ASTHMATICS TREATED WITH BUDESONIDE 41
Ruolo dell’endotelio nella regolazione del circolo polmonare 41
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 41
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 41
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 41
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 41
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 41
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 40
Treatment of COPD by dual bronchodilation with co-formulation of indacaterol/glycopyrronium 40
Patogenesi e terapia dell’asma bronchiale: recenti acquisizioni, 40
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer 40
Phenotyping severe asthma: a rationale for biologic therapy 40
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 40
Enfisema polmonare 39
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 39
Fisiopatologia del Broncospasmo 39
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 39
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 38
Applicazioni della Biologia Molecolare alle Malattie Respiratorie 38
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells 38
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 38
Characteristics and treatment regimens across ERS SHARP severe asthma registries 38
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 38
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 38
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study 38
Totale 4.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 24 13 7 6 86 25 6 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.733 412 137 97 105 196 345 93 75 351 145 284 493
2025/20263.754 325 755 765 1.271 638 0 0 0 0 0 0 0
Totale 9.908